Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-25 @ 9:14 AM
Study NCT ID:
NCT05639192
Status:
TERMINATED
Last Update Posted:
2023-08-29
First Post:
2022-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
Sponsor:
Apogenix GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APG101_CD_018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None